Omada Health, Inc.·4/A

Jul 8, 8:22 PM ET

Duffy Sean P. 4/A

4/A · Omada Health, Inc. · Filed Jul 8, 2026

Research Summary

AI-generated summary of this filing

Updated

Omada (OMDA) CEO Sean Duffy Exercises Options, Sells 17,258 Shares

What Happened

  • Sean P. Duffy, CEO of Omada Health (OMDA), exercised a total of 17,258 option shares and sold those same shares in same-day exercise-and-sale transactions on June 24–26, 2026. Exercises included 2,800 shares @ $5.82 (6/24), 300 @ $5.82 (6/25), 9,844 @ $5.82 (6/26) and 4,314 @ $8.28 (6/26). Total exercise cost reported: ~$111,054. The corresponding open-market sales were: 2,800 shares @ $19.01, 300 @ $19.00, 9,844 @ $19.61 (weighted avg), and 4,314 @ $20.90 (weighted avg), producing aggregate proceeds of about $342,116. The Form 4/A also shows corresponding derivative dispositions at $0 reflecting the options cancelled on exercise.

Key Details

  • Transaction dates: June 24, 25 and 26, 2026; sale prices reported as weighted averages where multiple trades occurred.
  • Shares sold: 17,258; aggregate sale proceeds ≈ $342,116. Aggregate cash paid to exercise ≈ $111,054.
  • Filing status: This is an amended Form 4 (Form 4/A). The amendment restates the original 6/26/2026 filing to report exercises that were inadvertently omitted; the sales had been timely reported originally. (See footnote F1.)
  • 10b5-1 plan: At least some transactions were executed pursuant to a 10b5-1 trading plan adopted March 13, 2026 (F2).
  • Multiple-trade reporting: Some sales executed in multiple trades at slightly varying prices; reported amounts are weighted averages (F3, F4).
  • Options/status: 100% of the shares subject to the option were fully vested and exercisable (F6). Some shares are held in family trusts; the reporting person disclaims beneficial ownership of those except to the extent of pecuniary interest (F5).

Context

  • These were cashless, same-day exercise-and-sale transactions (exercise followed by immediate sale), a common way for insiders to monetize vested options; such transactions do not necessarily indicate a change in view of the company. The amendment corrects previously omitted exercise entries so the beneficial ownership totals were adjusted on the amended Form 4/A.

Insider Transaction Report

Form 4/AAmended
Period: 2026-06-24
Duffy Sean P.
DirectorChief Executive Officer
Transactions
  • Exercise/Conversion

    Common Stock

    [F1]
    2026-06-24$5.82/sh+2,800$16,296414,661 total
  • Sale

    Common Stock

    [F2][F3][F1]
    2026-06-24$19.01/sh2,800$53,239411,861 total
  • Exercise/Conversion

    Common Stock

    [F1]
    2026-06-25$5.82/sh+300$1,746412,161 total
  • Sale

    Common Stock

    [F2][F4][F1]
    2026-06-25$19.00/sh300$5,701411,861 total
  • Exercise/Conversion

    Common Stock

    [F1]
    2026-06-26$5.82/sh+9,844$57,292421,705 total
  • Sale

    Common Stock

    [F2][F1]
    2026-06-26$19.61/sh9,844$193,013411,861 total
  • Exercise/Conversion

    Common Stock

    [F1]
    2026-06-26$8.28/sh+4,314$35,720416,175 total
  • Sale

    Common Stock

    [F2][F1]
    2026-06-26$20.90/sh4,314$90,163411,861 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    [F1][F6]
    2026-06-242,800178,515 total
    Exercise: $5.82Exp: 2029-08-21Common Stock (2,800 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    [F1][F6]
    2026-06-25300178,215 total
    Exercise: $5.82Exp: 2029-08-21Common Stock (300 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    [F1][F6]
    2026-06-269,844168,371 total
    Exercise: $5.82Exp: 2029-08-21Common Stock (9,844 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    [F1][F6]
    2026-06-264,314129,019 total
    Exercise: $8.28Exp: 2031-05-05Common Stock (4,314 underlying)
Holdings
  • Common Stock

    [F5]
    (indirect: See footnote)
    851,659
Footnotes (6)
  • [F1]This Form 4/A restates in its entirety the original Form 4 filed on 6/26/2026 to report exercise transactions that were inadvertently omitted from the original filing. The exercises reported herein were part of same-day exercise-and-sale transactions, and the corresponding sales were timely reported in the original Form 4. Due to the omission of these exercise transactions, the amount of securities beneficially owned following the sales was understated. The amount of securities beneficially owned has been adjusted in Box 5 of Table I of this Form 4/A to correct the aforementioned error.
  • [F2]Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.
  • [F3]This transaction was executed in multiple trades at prices ranging from $19.00 to $19.03. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F4]This transaction was executed in multiple trades at prices ranging from $19.00 to $19.01. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F5]Held in family trusts for the benefit of the Reporting Person's family members. The Reporting Person disclaims beneficial ownership of the shares held by the family trusts except to the extent of his pecuniary interest therein.
  • [F6]100% of the shares subject to the option are fully vested and exercisable
Signature
/s/ Nathan Salha, as Attorney-in-Fact for Sean P. Duffy|2026-07-08

Documents

1 file
  • 4
    form4a.xml

    FORM 4/A